ORLANDO – Up to half of all cases of Alzheimer’s disease are attributable to seven modifiable risk factors – including depression, Dr. Kristine Yaffe asserted in her 2014 AAGP Distinguished Scientist...
ORLANDO – Duloxetine for the treatment of late-life depression missed its primary end point in a recent large randomized trial, but it did result in consistently significant clinical improvement,...
Patients with mild cognitive impairment were 80% more likely to die over a 6-year period than cognitively normal patients.
The risks were significantly elevated for both patients with amnestic and...
ORLANDO – The bad news about antidepressant therapy for patients whose first episode of depression occurs in late life is that the randomized trials show it’s no better than placebo. The good news is...
ORLANDO – Do SSRIs actually work for late-life generalized anxiety disorder?
"I think the answer is, ‘Yes, a little.’ The benefits are limited in the randomized controlled trials and in my own...
ORLANDO – Transition to an assisted-living facility or nursing home is a period of high risk for suicide among the elderly – as well as an opportunity for preventive intervention.
That was the key...
WASHINGTON – A collaborative care program that supports both Alzheimer’s patients and caregivers saved an Indiana health care system more than $1 million during its initial yearlong test period.
The...
ORLANDO – The mortality risk associated with prescription of antipsychotics or valproic acid for behavioral disturbances in patients with dementia is considerably greater than previously estimated,...